Synexis Biodefense Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Synexis Biodefense's estimated annual revenue is currently $16.6M per year.(i)
  • Synexis Biodefense's estimated revenue per employee is $202,256

Employee Data

  • Synexis Biodefense has 82 Employees.(i)
  • Synexis Biodefense grew their employee count by -4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.3M2191%N/AN/A
#2
$0.4M60%N/AN/A
#3
$13.5M730%N/AN/A
#4
$2.3M120%N/AN/A
#5
$0.5M70%N/AN/A
#6
$0.6M10-17%N/AN/A
#7
$0.6M100%N/AN/A
#8
$1M160%N/AN/A
#9
$2.7M22-39%N/AN/A
#10
$16.6M68-24%N/AN/A
Add Company

Synexis? provides sustainable, wide-area reduction of microbial levels in occupied spaces. Our patented Dry Hydrogen Peroxide (DHP) technology uses a building?s ambient humidity and oxygen to continuously achieve safe, green, natural, reduction of viruses, bacteria, and mold in the air and on surfaces. DHP technology is inexpensive, highly scalable, and can be installed standalone or in existing HVAC systems.

keywords:N/A

N/A

Total Funding

82

Number of Employees

$16.6M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Synexis Biodefense News

2022-04-20 - New Elk Valley Casino officially opens today | News

Elk Valley Casino features a state-of-the-art fresh air ventilation system equipped with the Synexis Bio-Defense System to combat viruses,...

2022-04-17 - Synexis® sharpens focus on healthcare market, announces ...

Synexis develops cutting-edge BioDefense systems designed to transform the air to make the air and surfaces cleaner. Synexis BioDefense...

2022-04-13 - Experts eye ventilation improvements as COVID spikes continue

Some in the biodefense community, like Eric Schlote's company Synexis, ... The Synexis CEO argues indoor air quality is a national security...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.6M82-1%N/A
#2
$3.5M821%N/A
#3
$24.8M8211%N/A
#4
$23.8M83-2%N/A
#5
$29.5M8411%N/A